Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
  1. 2020
  2. Published

    Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS

    ABIRISK Consortium, 4 Nov 2020, In: BMC Medicine. 18, 1, p. 298

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium

    ABIRISK Consortium, Oct 2020, In: PLOS Medicine. 17, 10, p. e1003348

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. 2019
  5. Published
  6. Published

    Serum and cerebrospinal fluid neurofilament levels predict longitudinal atrophy of the cervical spinal cord in progressive MS

    Lundell, H., Christensen, J. R., Börnsen, L. S., Ammitzbøll, C., Søndergaard, H. B., Jensen, P. E. H., Iversen, P., Sørensen, P. S., Garde, E., Sellebjerg, F. T. & Siebner, H. R., 10 Sep 2019, In: Multiple Sclerosis Journal. 25, 2_suppl, p. 469-470 1 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  7. Published

    Diagnostic value of oligoclonal bands in children: A Nationwide Population-Based Cohort Study

    Boesen, M. S., Born, A. P., Jensen, P. E. H., Sellebjerg, F., Blinkenberg, M., Lydolph, M. C., Jørgensen, M. K., Rosenberg, L., Thomassen, J. Q. & Børresen, M. L., Aug 2019, In: Pediatric Neurology. 97, p. 56-63 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published
  9. Published

    Prediction of natalizumab anti-drug antibodies persistency

    Deisenhammer, F., Jank, M., Lauren, A., Sjödin, A., Ryner, M., Fogdell-Hahn, A., Sievers, C., Lindberg, R., Jensen, P. E. H., Sellebjerg, F., Christodoulou, L., Birchler, M., Pallardy, M., Auer, M., Liblau, R. & ABIRISK Consortium, Mar 2019, In: Multiple sclerosis. 25, 3, p. 392-398 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study

    Jensen, P. E. H., Warnke, C., Ingenhoven, K., Piccoli, L., Gasis, M., Hermanrud, C., Fernandez-Rodriguez, B. M., Ryner, M., Kramer, D., Link, J., Ramanujam, R., Auer, M., Buck, D., Grummel, V., Bertotti, E., Fissolo, N., Oliver-Martos, B., Nytrova, P., Khalil, M., Guger, M., Rathmaier, S., Sievers-Stober, C., Lindberg, R. L. P., Hässler, S., Bachelet, D., Aktas, O., Donnellan, N., Lawton, A., Hemmer, B., Havrdova, E. K., Kieseier, B., Hartung, H-P., Comabella, M., Montalban, X., Derfuss, T., Sellebjerg, F., Dönnes, P., Pallardy, M., Spindeldreher, S., Broët, P., Deisenhammer, F., Fogdell-Hahn, A., Sorensen, P. S. & ABIRISK Consortium, 15 Jan 2019, In: Journal of Neuroimmunology. 326, p. 19-27 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. 2018
  12. Published

    Oral Immunosuppressive Treatment of Myasthenia Gravis in Denmark: A Nationwide Drug Utilization Study, 1996-2013

    Pedersen, E. G., Hallas, J., Pottegård, A., Hald, S. M., Jensen, P. E. H. & Gaist, D., Oct 2018, In: Basic & clinical pharmacology & toxicology. 123, 4, p. 486-493 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Clinical utility of anti-MOG antibody testing in a Danish cohort

    Papp, V., Langkilde, A. R., Blinkenberg, M., Schreiber, K., Jensen, P. E. H. & Sellebjerg, F., 11 Sep 2018, In: Multiple Sclerosis and Related Disorders. 26, p. 61-67 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published
  15. Published

    Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark

    Papp, V., Illes, Z., Magyari, M., Koch-Henriksen, N., Kant, M., Pfleger, C. C., Roemer, S. F., Jensen, M. B., Petersen, A. E., Nielsen, H. H., Rosendahl, L., Mezei, Z., Christensen, T., Svendsen, K., Hyldgaard Jensen, P. E., Lydolph, M. C., Heegaard, N., Frederiksen, J. L., Sellebjerg, F., Stenager, E. & Petersen, T., 2018, In: Neurology. 91, 24, p. e2265-e2275

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. 2017
  17. Published

    Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

    Link, J., Ramanujam, R., Auer, M., Ryner, M., Hässler, S., Bachelet, D., Mbogning, C., Warnke, C., Buck, D., Hyldgaard Jensen, P. E., Sievers, C., Ingenhoven, K., Fissolo, N., Lindberg, R., Grummel, V., Donnellan, N., Comabella, M., Montalban, X., Kieseier, B., Soelberg Sørensen, P., Hartung, H-P., Derfuss, T., Lawton, A., Sikkema, D., Pallardy, M., Hemmer, B., Deisenhammer, F., Broët, P., Dönnes, P., Davidson, J., Fogdell-Hahn, A. & ABIRISK Consortium, 2017, In: P L o S One. 12, 2, p. e0170395

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Development and Validation of an Enzyme-Linked Immunosorbent Assay for the Detection of Binding Anti-Drug Antibodies against Interferon Beta

    Ingenhoven, K., Kramer, D., Jensen, P. E. H., Hermanrud, C., Ryner, M., Deisenhammer, F., Pallardy, M., Menge, T., Hartung, H-P., Kieseier, B. C., Bertotti, E., Creeke, P., Fogdell-Hahn, A. & Warnke, C., 2017, In: Frontiers in Neurology. 8, p. 305 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. 2016
  20. Published
  21. Published

    Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis

    Bachelet, D., Hässler, S., Mbogning, C., Link, J., Ryner, M., Ramanujam, R., Auer, M., Hyldgaard Jensen, P. E., Koch-Henriksen, N., Warnke, C., Ingenhoven, K., Buck, D., Grummel, V., Lawton, A., Donnellan, N., Hincelin-Mery, A., Sikkema, D., Pallardy, M., Kieseier, B., Hemmer, B., Hartung, H. P., Soelberg Sorensen, P., Deisenhammer, F., Dönnes, P., Davidson, J., Fogdell-Hahn, A., Broët, P. & ABIRISK Consortium, 2016, In: P L o S One. 11, 11, p. e0162752

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. 2015
  23. Published

    Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium

    Rup, B., Pallardy, M., Sikkema, D., Albert, T., Allez, M., Broet, P., Carini, C., Creeke, P., Davidson, J., De Vries, N., Finco, D., Fogdell-Hahn, A., Havrdova, E., Hincelin-Mery, A., C Holland, M., H Jensen, P. E., Jury, E. C., Kirby, H., Kramer, D., Lacroix-Desmazes, S., Legrand, J., Maggi, E., Maillère, B., Mariette, X., Mauri, C., Mikol, V., Mulleman, D., Oldenburg, J., Paintaud, G., R Pedersen, C., Ruperto, N., Seitz, R., Spindeldreher, S., Deisenhammer, F. & ABIRISK Consortium, Sep 2015, In: Clinical and Experimental Immunology. 181, 3, p. 385-400 16 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    Genetic variants are major determinants of CSF antibody levels in multiple sclerosis

    Goris, A., Pauwels, I., Gustavsen, M. W., van Son, B., Hilven, K., Bos, S. D., Celius, E. G., Berg-Hansen, P., Aarseth, J., Myhr, K-M., D'Alfonso, S., Barizzone, N., Leone, M. A., Martinelli Boneschi, F., Sorosina, M., Liberatore, G., Kockum, I., Olsson, T., Hillert, J., Alfredsson, L., Bedri, S. K., Hemmer, B., Buck, D., Berthele, A., Knier, B., Biberacher, V., van Pesch, V., Sindic, C., Oturai, A., Søndergaard, H. B., Sellebjerg, F., Jensen, P. E. H., Comabella, M., Montalban, X., Pérez-Boza, J., Malhotra, S., Lechner-Scott, J., Broadley, S., Slee, M., Taylor, B., Kermode, A. G., Gourraud, P-A., Sawcer, S. J., Andreassen, B. K., Dubois, B., Harbo, H. F. & International Multiple Sclerosis Genetics Consortium, Mar 2015, In: Brain. 138, Pt 3, p. 632-43 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. 2014
  26. Published

    Myasthenia and risk of cancer: a population-based case-control study

    Pedersen, E. G., Pottegård, A., Hallas, J., Friis, S., Hansen, K., Jensen, P. E. H. & Gaist, D., May 2014, In: European journal of neurology : the official journal of the European Federation of Neurological Societies. 21, 5, p. 773-8 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published

    Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine

    Pedersen, E. G., Pottegård, A., Hallas, J., Friis, S., Hansen, K., Jensen, P. E. H. & Gaist, D., 2014, In: European journal of neurology : the official journal of the European Federation of Neurological Societies. 21, 3, p. 454-58

    Research output: Contribution to journalJournal articleResearchpeer-review

  28. 2013
  29. Published

    Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort

    Olsson, T., Achiron, A., Alfredsson, L., Berger, T., Brassat, D., Chan, A., Comi, G., Eraksoy, M., Hegen, H., Hillert, J., Jensen, P. E. H., Moiola, L., Myhr, K-M., Oturai, A., Schippling, S., Siva, A., Sorensen, P. S., Trampe, A-K., Weber, T., Potts, J., Plavina, T., Paes, D., Subramanyam, M., Wiendl, H., Dib, H., Uren, D., Hemmer, B. & Buck, D., Oct 2013, In: Multiple sclerosis. 19, 11, p. 1533-8 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  30. Published

    Use of azathioprine for non-thymoma myasthenia and risk of cancer: a nationwide case-control study in Denmark

    Pedersen, E. G., Pottegård, A., Hallas, J., Friis, S., Hansen, K., Jensen, P. E. H. & Gaist, D., Jun 2013, In: European journal of neurology : the official journal of the European Federation of Neurological Societies. 20, 6, p. 942-8 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  31. Published

    CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis

    Romme Christensen, J., Börnsen, L., Khademi, M., Olsson, T., Jensen, P. E., Sørensen, P. S. & Sellebjerg, F., 2013, In: Multiple Sclerosis. 19, 7, p. 877-84

    Research output: Contribution to journalJournal articleResearchpeer-review

  32. Published

    Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996-2009

    Pedersen, E. G., Hallas, J., Hansen, K., Jensen, P. E. H. & Gaist, D., 2013, In: European Journal of Neurology. 20, 2, p. 309-14 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  33. 2012
  34. Published
  35. Published

    Prediction of antibody persistency from antibody titres to natalizumab

    Jensen, P. E. H., Koch-Henriksen, N., Sellebjerg, F. & Sørensen, P. S., 2012, In: Multiple Sclerosis. 18, 10, p. 1493-9 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  36. 2011
  37. Published

    Identifying patients with myasthenia for epidemiological research by linkage of automated registers

    Pedersen, E. G., Hallas, J., Hansen, K., Jensen, P. E. H. & Gaist, D., 2011, In: Neuroepidemiology. 37, 2, p. 120-8 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  38. Published

    Neutralizing antibodies against interferon-β do not predispose antibodies against natalizumab

    Sørensen, P. S., Koch-Henriksen, N. & Jensen, P. E. H., 2011, In: Neurology. 76, 8, p. 759-60 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  39. Published

    Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab

    Sørensen, P. S., Jensen, P. E. H., Haghikia, A., Lundkvist, M., Vedeler, C., Sellebjerg, F., Koch-Henriksen, N., Fogdell-Hahn, A., Myhr, K-M., Hillert, J. & Gold, R., 2011, In: Multiple Sclerosis. 17, 9, p. 1074-8 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  40. 2009
  41. Published

    Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis

    Ravnborg, M., Bendtzen, K., Christensen, O., Jensen, P. E. H., Hesse, D., Tovey, M. G. & Sørensen, P. S., 1 Mar 2009, In: Multiple Sclerosis. 15, 3, p. 323-8 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  42. Published

    Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation

    Sellebjerg, F. T., Krakauer, M., Hesse, D., Ryder, L. P., Alsing, I., Jensen, P. E. H., Koch-Henriksen, N., Svejgaard, A. & Sørensen, P. S., 2009, In: European Journal of Neurology. 16, 12, p. 1291-8 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 30998814